Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 40 are a BUY (74.07%), 12 are a HOLD (22.22%), 2 are a SELL (3.7%).
Analyst Whitney Ijem works at CANACCORD with a stock forecast success ratio of 30.48% fulfilled within 205.22 days on average.
Whitney Ijem’s has documented 107 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 26-Apr-2024.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
175
$41.34 (30.93%)
177
3 days ago
9/16 (56.25%)
$41.34 (30.93%)
125
Hold
128
$-5.66 (-4.23%)
128
4 days ago
3/9 (33.33%)
$-2.63 (-2.01%)
61
Buy
166
$32.34 (24.20%)
166
4 days ago
8/20 (40%)
$35.37 (27.08%)
248
Buy
167
$33.34 (24.94%)
174
2 months 5 days ago
1/6 (16.67%)
$38.33 (29.79%)
39
Buy
172
$38.34 (28.68%)
113
2 months 7 days ago
1/3 (33.33%)
$44.1 (34.48%)
27
Which stock is Whitney Ijem is most bullish on?
Which stock is Whitney Ijem is most reserved on?
What Year was the first public recommendation made by Whitney Ijem?